168 related articles for article (PubMed ID: 32639532)
1. Enantioseparation, in vitro testing, and structural characterization of triple-binding reactivators of organophosphate-inhibited cholinesterases.
Maraković N; Knežević A; Rončević I; Brazzolotto X; Kovarik Z; Šinko G
Biochem J; 2020 Aug; 477(15):2771-2790. PubMed ID: 32639532
[TBL] [Abstract][Full Text] [Related]
2. Butyrylcholinesterase inhibited by nerve agents is efficiently reactivated with chlorinated pyridinium oximes.
Zorbaz T; Malinak D; Kuca K; Musilek K; Kovarik Z
Chem Biol Interact; 2019 Jul; 307():16-20. PubMed ID: 31004594
[TBL] [Abstract][Full Text] [Related]
3. Cholesterol Oxime Olesoxime Assessed as a Potential Ligand of Human Cholinesterases.
Kolić D; Šinko G; Jean L; Chioua M; Dias J; Marco-Contelles J; Kovarik Z
Biomolecules; 2024 May; 14(5):. PubMed ID: 38785995
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of high-affinity phenyltetrahydroisoquinoline aldoximes, linked through anti-triazoles, as reactivators of phosphylated cholinesterases.
Maček Hrvat N; Kalisiak J; Šinko G; Radić Z; Sharpless KB; Taylor P; Kovarik Z
Toxicol Lett; 2020 Mar; 321():83-89. PubMed ID: 31863869
[TBL] [Abstract][Full Text] [Related]
5. Centrally acting oximes in reactivation of tabun-phosphoramidated AChE.
Kovarik Z; Maček N; Sit RK; Radić Z; Fokin VV; Barry Sharpless K; Taylor P
Chem Biol Interact; 2013 Mar; 203(1):77-80. PubMed ID: 22960624
[TBL] [Abstract][Full Text] [Related]
6. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
Bartling A; Worek F; Szinicz L; Thiermann H
Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
[TBL] [Abstract][Full Text] [Related]
7. New Heterostilbene and Triazole Oximes as Potential CNS-Active and Cholinesterase-Targeted Therapeutics.
Mlakić M; Čadež T; Šinko G; Škorić I; Kovarik Z
Biomolecules; 2024 Jun; 14(6):. PubMed ID: 38927082
[TBL] [Abstract][Full Text] [Related]
8. Pyridoxal oxime derivative potency to reactivate cholinesterases inhibited by organophosphorus compounds.
Bušić V; Katalinić M; Šinko G; Kovarik Z; Gašo-Sokač D
Toxicol Lett; 2016 Nov; 262():114-122. PubMed ID: 27693733
[TBL] [Abstract][Full Text] [Related]
9. Reactivation of organophosphate-inhibited serum butyrylcholinesterase by novel substituted phenoxyalkyl pyridinium oximes and traditional oximes.
Nichols RH; Chambers JE
Toxicology; 2021 Mar; 452():152719. PubMed ID: 33592259
[TBL] [Abstract][Full Text] [Related]
10. Molecular Modeling Studies on the Multistep Reactivation Process of Organophosphate-Inhibited Acetylcholinesterase and Butyrylcholinesterase.
Jończyk J; Kukułowicz J; Łątka K; Malawska B; Jung YS; Musilek K; Bajda M
Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33513955
[TBL] [Abstract][Full Text] [Related]
11. Exploring the physicochemical properties of oxime-reactivation therapeutics for cyclosarin, sarin, tabun, and VX inactivated acetylcholinesterase.
Esposito EX; Stouch TR; Wymore T; Madura JD
Chem Res Toxicol; 2014 Jan; 27(1):99-110. PubMed ID: 24443939
[TBL] [Abstract][Full Text] [Related]
12. Pseudo-catalytic scavenging: searching for a suitable reactivator of phosphorylated butyrylcholinesterase.
Kovarik Z; Katalinić M; Sinko G; Binder J; Holas O; Jung YS; Musilova L; Jun D; Kuca K
Chem Biol Interact; 2010 Sep; 187(1-3):167-71. PubMed ID: 20206154
[TBL] [Abstract][Full Text] [Related]
13. Oxime-mediated in vitro reactivation kinetic analysis of organophosphates-inhibited human and electric eel acetylcholinesterase.
Sahu AK; Sharma R; Gupta B; Musilek K; Kuca K; Acharya J; Ghosh KK
Toxicol Mech Methods; 2016 Jun; 26(5):319-26. PubMed ID: 27101948
[TBL] [Abstract][Full Text] [Related]
14. Nonquaternary reactivators for organophosphate-inhibited cholinesterases.
Kalisiak J; Ralph EC; Cashman JR
J Med Chem; 2012 Jan; 55(1):465-74. PubMed ID: 22206546
[TBL] [Abstract][Full Text] [Related]
15. Reactivation kinetics of 31 structurally different bispyridinium oximes with organophosphate-inhibited human butyrylcholinesterase.
Horn G; Wille T; Musilek K; Kuca K; Thiermann H; Worek F
Arch Toxicol; 2015 Mar; 89(3):405-14. PubMed ID: 24912784
[TBL] [Abstract][Full Text] [Related]
16. Halogen substituents enhance oxime nucleophilicity for reactivation of cholinesterases inhibited by nerve agents.
Zorbaz T; Malinak D; Hofmanova T; Maraković N; Žunec S; Hrvat NM; Andrys R; Psotka M; Zandona A; Svobodova J; Prchal L; Fingler S; Katalinić M; Kovarik Z; Musilek K
Eur J Med Chem; 2022 Aug; 238():114377. PubMed ID: 35526478
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic studies of new oximes reactivators of human butyryl cholinesterase inhibited by cyclosarin and sarin.
de Lima WE; Francisco A; da Cunha EF; Radic Z; Taylor P; França TC; Ramalho TC
J Biomol Struct Dyn; 2017 May; 35(6):1272-1282. PubMed ID: 27125569
[TBL] [Abstract][Full Text] [Related]
18. In vitro ability of currently available oximes to reactivate organophosphate pesticide-inhibited human acetylcholinesterase and butyrylcholinesterase.
Jun D; Musilova L; Musilek K; Kuca K
Int J Mol Sci; 2011; 12(3):2077-87. PubMed ID: 21673941
[TBL] [Abstract][Full Text] [Related]
19. Charged pyridinium oximes with thiocarboxamide moiety are equally or less effective reactivators of organophosphate-inhibited cholinesterases compared to analogous carboxamides.
Kohoutova Z; Malinak D; Andrys R; Svobodova J; Psotka M; Schmidt M; Prchal L; Musilek K
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):760-767. PubMed ID: 35193448
[TBL] [Abstract][Full Text] [Related]
20. Reactivation kinetics of a homologous series of bispyridinium bis-oximes with nerve agent-inhibited human acetylcholinesterase.
Worek F; von der Wellen J; Musilek K; Kuca K; Thiermann H
Arch Toxicol; 2012 Sep; 86(9):1379-86. PubMed ID: 22437842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
